Venus Concept, a prominent player in the global medical aesthetic technology market, has announced a strategic move to bolster its financial position. The company has entered into definitive agreements for a registered direct offering, aiming to raise approximately $1.15 million upfront. This initial injection of capital will be further augmented by the potential for an additional $2.3 million in gross proceeds, contingent upon the full exercise of unregistered short-term warrants.
The offering involves the sale of 434,720 shares of common stock at a price of $2.65 per share. Accompanying this is a private placement of unregistered short-term warrants, allowing investors to purchase up to 869,440 shares of common stock, also at $2.65 per share. These warrants are immediately exercisable upon issuance and will expire eighteen months after the effective date of the registration statement. The deal is expected to close around June 9, 2025, pending customary closing conditions.
The company intends to deploy the net proceeds from this offering for general corporate purposes. With a shelf registration statement already in place, the shares are being offered via a prospectus, which will be filed with the SEC.
A Look at Venus Concept
Venus Concept is a key innovator in the medical aesthetics sector, offering a diverse portfolio of both minimally invasive and non-invasive technologies. Their reach extends to over 60 countries with direct market presence in nine key areas. Their product lines include devices like Venus Versa, Venus Legacy, and Venus Bliss, among others, alongside hair restoration systems. Venus Concept is supported by leading investors in the healthcare industry.
Disclaimer
This communication contains forward-looking statements that are based on current expectations, estimates, and projections about the Company’s business and are not guarantees of future performance or developments. Actual results may differ materially.
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/1907.html
